Red blood cells (RBCs) have historically been considered passive bystanders in
thrombosis. However, clinical and epidemiological studies have associated quantitative and …

It has been long known that blood health heavily influences optimal physiological function.
Abnormalities affecting the physical properties of blood have been implicated in the …

The flow properties of blood play significant roles in tissue perfusion by contributing to
hydrodynamic resistance in blood vessels. These properties are influenced by …

Red blood cells (RBCs) demonstrate procoagulant properties in vitro, and elevated
hematocrit is associated with reduced bleeding and increased thrombosis risk in humans …

Thrombocytosis is a commonly encountered clinical scenario, with a large proportion of
cases discovered incidentally. The differential diagnosis for thrombocytosis is broad and the …

Hypogonadism in older men is a syndrome characterized by low serum testosterone levels
and clinical symptoms often seen in hypogonadal men of younger age. These symptoms …

Thrombophilia, which severely impacts on morbidity and mortality of polycythaemia vera and
essential thrombocythaemia, is variably characterized by microcirculatory disturbances …

Recent randomized, controlled trials indicate that there is a strong trend for increased risk for
death or adverse composite outcomes with erythropoiesis-stimulating agent treatment in …

Chronic Mountain Sickness (CMS) is an important high-altitude (HA) pathology in most
mountainous regions of the world. Although its most characteristic sign is excessive …

The synthesis of erythropoiesis-stimulating agents (ESAs), especially recombinant human
erythropoietin, has provided a new therapeutic option for the treatment of patients with …